Tevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totaling 81,430 shares, a growth of 4,063.1% from the July 15th total of 1,956 shares. Based on an average daily trading volume, of 543,502 shares, the days-to-cover ratio is currently 0.1 days.
Tevogen Bio Price Performance
Shares of TVGNW stock traded down $0.00 on Tuesday, hitting $0.05. The stock had a trading volume of 6,900 shares, compared to its average volume of 188,174. The company’s 50 day moving average price is $0.05 and its 200-day moving average price is $0.04. Tevogen Bio has a 1 year low of $0.03 and a 1 year high of $0.08.
Tevogen Bio Company Profile
Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.
The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.
See Also
- Five stocks we like better than Tevogen Bio
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
